Vection Technologies (ASX:VR1) gains on healthcare & pharma solutions division launch

Vection Technologies Limited (ASX:VR1) gained as much as 14.6% to A$0.11 per share, its highest since 3 March 2021. 

It should be noted that the Company has announced the launch of its healthcare and pharma solutions division, and the stock has risen for the fourth consecutive session.

Around 4.6 million shares were traded as compared to the 30-day average of about 4.1 million shares. 

However, the stock has declined 20% this year as of the last close, VR1 was trading 2.083% higher at A$0.098 per share with a market cap of A$92.72 million at 1:00 PM AEDT.

 

Comment


Disclaimer

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK